The tumor propensity of the macrophage membrane and receptor-mediated endocytosis of endothelin-2 peptide could help the nano-delivery system to efficiently cross the Blood Tumor Barrier (BTB) and target Glioblastoma Multiforme (GBM) regions. This evidence concerns the gene EDN2 and glioblastoma.